Trytosaveabit commented on a stock · Dec 4, 2023 06:14

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite Biopharma Has Completed The Design Of Phase 2A Study Protocol For Pancreatic Cancer And Plans To Submit The Protocol Shortly To Ethical Committees For Approval, Study Will Aim To Enroll About 20 Patients To Establish Safety And Clinical Activity

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1366 Views

Comment

Trytosaveabit

1819Followers

29Following

22KVisitors